Medneo accelerates growth and enters veterinary imaging with acquisition of Burgess Diagnostics
21 Sep 2026
We are pleased to announce that Medneo has acquired Burgess Diagnostics Ltd, 21st September 2026. Read more
An adult Bichon Frise first presented, aged 9 years, with seizures. CSF, bloods and MRI at initial presentation were all said to be normal and the dog responded well to medical treatment.

Initial MRI (T2W TSE)
Some nine months later, deterioration in seizure control occurred with the dog experiencing a cluster of seizures. Medication was increased and the patient was referred for a second MRI. On this occasion an ill-defined area of T2W hyperintensity was found in the ventral aspect of the right temporal lobe and hippocampus with corresponding T1W hypointensity.

T2W TSE T1W IR
Diffusion weighted imaging was not available at the time of the initial scan as this was carried out on a low-field scanner but DWI on this occasion demonstrated no evidence of restricted diffusion. A diagnosis of non-haemorrhagic infarct was made.

DWI
21 Sep 2026
We are pleased to announce that Medneo has acquired Burgess Diagnostics Ltd, 21st September 2026. Read more
14 Sep 2026
In August 2026 the Burgess Diagnostics mobile imaging team had the privilege of supporting the Animal Care team at Colchester Zoo for a full day of advanced CT imaging. The visit formed part of Colchester Zoological Society’s commitment to delivering exceptional standards of animal care, using this state-of-the-art diagnostic tool to better understand the health of the extraordinary animals in their care. Read more